With the addition of new members, the Orbitrap mass spectrometry family has helped to break through the difficulties of omics research

Since its introduction, metabolomics and lipidomics have rapidly developed into an important part of systems biology, playing an important role
in the research of metabolic diseases, Alzheimer's disease, diabetes, obesity, non-alcoholic fatty liver disease and tumors 。 Recently, the latest academic results of the research group of Researcher Zhu Zhengjiang and Researcher Liu Nan of the Interdisciplinary Research Center for Biology and Chemistry of the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences were published in the journal Nature Communications, which applies the non-targeted metabolic flow omics technology based on stable isotope markers, and reveals the metabolic homeostasis changes that occur during the aging process of Drosophila at the system level.
Among them, MetTracer technology has applied for a national invention patent
.
Recently, we had the honor to come to the Laboratory of Mass Spectrometry and Metabolomics, a researcher with Zhu Zhengjiang, and invited him to share the challenges and coping methods of metabolomics, explain in detail the characteristics of mass spectrometry in metabolomics research and clinical applications, and look forward to the future development trend
of metabolomics and mass spectrometry.